Spravato TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: esketamine
Brand name
(ARTG)
: SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solutionDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
SPRAVATO is indicated for treatment resistant depression (Major Depressive Disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,SPRAVATO is to be initiated in conjunction with a newly initiated oral antidepressant.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Spray, nasal
- Nasal
- Clear colourless to slightly yellowish aqueous solution packaged in Type 1 glass vial, rubber stopper and assemble inside a single use nasal spray device
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 48 Months.
- Store below 25 degrees Celsius
- Shelf lifetime is 48 Months.
Do I need a prescription ?
(ARTG)
These medicines require authorisation for prescription from your doctor. It is
- 1 Nasal Spray (vial and device combination) pack
- 2 Nasal Spray (vial and device combination) pack
- 3 Nasal Spray (vial and device combination) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient esketamine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
